Kourosh Rezania is a Neurology physician affiliated with University of Chicago. OpenAlex indexes 166 publications with 2,437 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5841 S Maryland Ave
Chicago, IL 606371443
Telephone
888-824-0200Registry record last updated 24 Oct 2022.
Clinical trials
- Intermuscular Coherence as a Biomarker for ALS
Sponsor: University of Chicago
- The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy
Sponsor: University of Chicago
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year202520 payments$28,659openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year202512 payments$11,615openpaymentsdata.cms.gov ↗
- Grifols USA, LLCProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
58.8%Gabapentinoids20.9%Gabapentin62%Pregabalin38%Part D≥54 patientsSNRI12.9%Duloxetine Hcl100%Part D≥48 patients+ 8 more classes in this area
Respiratory
16%Opioid Agonist14.3%Hydrocodone-Acetaminophen100%Part D≥38 patientsCatecholamine1%Epinephrine100%Part D≥13 patients+ 1 more class in this area
Musculoskeletal
6.8%gamma-Aminobutyric Acid-ergic Agonist3.1%Baclofen100%Part D≥13 patientsMuscle Relaxant2.4%Carisoprodol50%Cyclobenzaprine Hcl50%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:
- Intermuscular coherence: A novel biomarker for upper motor neuron dysfunction in ALS
University of Chicago
FY2025$538,546R01NS116262 - Intermuscular coherence: A novel biomarker for upper motor neuron dysfunction in ALS
University of Chicago
FY2024$580,434R01NS116262 - Intermuscular coherence: A novel biomarker for upper motor neuron dysfunction in ALS
University of Chicago
FY2023$598,384R01NS116262
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”